Aortic valve repair is an attractive treatment option for patients with aortic valve insufficiency. Aortic insufficiency affects 0.5% of adults, or nearly 2.5 million people in the U.S. and Europe.
The HAART Aortic Valve Repair Technologies include internal annuloplasty rings, instrumentation, and repeatable implantation procedures developed specifically to simplify and standardize the aortic valve repair operation.
The HAART 300 Aortic Annuloplasty Device is elliptical in order to replicate the geometry of a healthy valve annulus. It is specifically designed to reduce annular dilatation, restore three-dimensional annular geometry, and serve as a framework to guide leaflet repair procedures.
The The HAART 200 Annuloplasty Device is designed to reduce and remodel the annulus to produce a standardized, symmetric anatomy that facilitates leaflet reconstruction.
The HAART 200 Aortic Annuloplasty Device is not available for sale outside of the U.S.
Internal, geometric ring annuloplasty produces significant annular remodeling that facilitates leaflet reconstruction and makes aortic valve repair a simpler and more reproducible procedure. Use of the HAART devices has given many surgeons the confidence to expand the use of aortic valve repair beyond just valve sparing root replacement to include patients with a broad range of underlying etiologies of aortic insufficiency.
Correct device sizing is determined from leaflet free-edge lengths to restore appropriate annular dimensions and commissure positioning for the patient’s individual leaflet anatomy.
Together, the HAART 300 and HAART 200 Aortic Annuloplasty Devices offer a comprehensive, standardized solution for trileaflet and bicuspid aortic valve repair.
The HAART Aortic Annuloplasty Devices are quickly becoming a method of choice for aortic valve repair. BioStable is committed to the science of evidenced based medicine and excited to share the research presentations listed here. We are focused on educating and growing the community of aortic valve repair surgeons by raising awareness surrounding the benefits and ease of use of the HAART portfolio.
BioStable and the HAART Aortic Valve Repair devices will be widely represented and discussed at the following events. Please join us!
AATS – AATS 99th Annual Meeting will be held in Toronto, Canada – May 4-7, 2019 – Booth 23.
EACTS – EACTS Aortic Valve Repair Summit will be held in Brussels, Belgium – June 20-21, 2019.
WTSA – 45th Western Thoracic Surgical Association Annual Meeting will be held in Olympic Valley, CA – June 26-29, 2019.
EACTS – 33rd EACTS Annual Meeting will be held in Lisbon, Portugal – October 3-5, 2019.
STSA – 66th STSA Annual Meeting in Marco Island, FL – November 6-9, 2019.
BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.
BioStable Science & Engineering, Inc.
2621 Ridgepoint Drive | Suite 100 | Austin, TX 78754
Phone: 512-386-1996 | Fax: 512-243-8450